publication date: Dec. 19, 2010
In this issue:
Remarks on HPV vaccines, SPORE funds create controversy for NCI’s John Niederhuber.
NCI official says he hopes to “put more money” into SPOREs.
AACR Meeting: Celebrex studies show benign polyp reduction, point to challenges in biomarker validation.
Advocacy: NCCS, ASCO petition FDA to set standards for expanded access programs.
Download (PDF 1.9MB)
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.